Tablets with improved drug substance dispersibility

Details for Australian Patent Application No. 2006218193 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Garcia, Eric; Tardio, Joseph; Page, Susanne; Bernigal, Nathalie

Agent Spruson & Ferguson

Pub. Number AU-A-2006218193

PCT Pub. Number WO2006/089674

Priority 05101458.7 25.02.05 EP

Filing date 16 February 2006

Wipo publication date 31 August 2006

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/089674 Priority application(s): WO2006/089674

7 January 2010 Amendment Made

  The nature of the amendment is: Amend the applicant name from F.Hoffmann-La Roche AG to F. Hoffmann-La Roche AG

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218216-Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression

2006218187-Transport of nanoand macromolecular structures into cytoplasm and nucleus of cells